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Despite the high frequency of upper respiratory tract (URT) infections and use of the nasal
mucosa as route for vaccination, the local immunemechanism and dissemination of effector
lymphocytes from the URT have been insufficiently characterized. To devise a single-cell
approach for studying the mucosal immune response in the URT, we explored URT-originat-
ing B effector lymphocytes in the circulation of patients with one of two common respiratory
infections, acute sinusitis or tonsillitis.
Methods
Patients with acute sinusitis (n = 13) or tonsillitis (n = 11) were investigated by ELISPOT for
circulating pathogen-specific antibody-secreting cells (ASCs) of IgA, IgG and IgM isotypes
approximately one week after the onset of symptoms. These cells’ potential to home into tis-
sues was explored by assessing their expression of tissue-specific homing receptors α4β7,
L-selectin, and cutaneous lymphocyte antigen (CLA).
Results
Pathogen-specific ASCs were detected in the circulation of all patients, with a geometric
mean of 115 (95% CI 46–282) /106 PBMC in sinusitis, and 48 (27–88) in tonsillitis. These
responses were mainly dominated by IgG. In sinusitis α4β7 integrin was expressed by 24%
of the ASCs, L-selectin by 82%, and CLA by 21%. The proportions for tonsillitis were 15%,
80%, and 23%, respectively. Healthy individuals had no ASCs.
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Conclusions
URT infections–acute sinusitis and tonsillitis–both elicited a response of circulating pathogen-
specific plasmablasts. Themagnitude of the response was greater in sinusitis than tonsillitis,
but the homing receptor profiles were similar. Human nasopharynx-associated lymphoid
structures were found to disseminate immune effector cells with a distinct homing profile.
Introduction
The human upper respiratory tract (URT) is repeatedly exposed to a large variety of inhaled
microbes; accordingly, upper respiratory tract infections (URTI) constitute the most common
reason for emergency room visits in primary health care [1, 2]. High infection incidences, influ-
enza epidemics, and increasing antimicrobial resistance among URT pathogens, all point to a
need for more efficient vaccination strategies to protect this entry portal. Despite this, the local
immune mechanisms defending the respiratory tract against pathogens have been incompletely
characterized. To understand the immunity elicited in the URT, more needs to be learned
about the targeting of the immune response from this site, i.e. the migration of nasopharynx-
originating immune effector cells in the body.
Mucosal antibodies are considered elementary in the mucosal defense of the URT, as they
interfere with the initial steps of infection, preventing a pathogen’s attachment, subsequent spread
and invasion [3, 4]. Antigen encounter in a mucosa-associated lymphoid tissue activates antigen-
specific lymphocytes which migrate to local lymph nodes and return via lymphatics and blood to
various mucosal surfaces, primarily the original site, to carry out their effector functions [5, 6].
The plasmablasts only appear transiently in the circulation [7–11]. Indeed, in studies applying the
right timing, circulating pathogen-specific plasmablast have been detected in upper respiratory
infections caused by respiratory viruses [12] as well as after intranasal vaccination [13–15].
The dissemination of the newly activated plasmablasts or ASCs, a tightly regulated multi-
step homing process, exhibits a significant degree of tissue selectivity [5, 6], where homing
receptors (HR) and chemokine receptors (CCR) serve a central function. Activated ASCs
express specific HRs and CCRs that recognize their specific ligands, addressins and chemo-
kines, in the effector tissues [5, 6]. Consequently, a restricted cell population homes to specific
tissues at a specific time. Tissue-specific HRs haven been identified: α4β7 integrin guides cells
to intestinal mucosa [16], L-selectin to peripheral lymph nodes [17], and cutaneous lympho-
cyte antigen (CLA) to skin tissues [18].
It is worthy of note that the site of antigen encounter affects the HR repertoire on activating
cells, and thus also the targeting of the specific immune response [6, 19–26].
As the localization of the effector lymphocytes can be influenced by the choice of immuniza-
tion route, each potential inductive site deserves thorough investigation. It is not fully known
which HRs guide cells to the respiratory tract, and the targeting of the response elicited at this
site has remained inadequately studied in humans. We set up a single-cell study to explore the
URT as an inductive site in natural bacterial infection. We characterized pathogen-specific
ASC response in patients with acute sinusitis or acute tonsillitis, focusing on HR expression on
ASCs and their trafficking potentials in the body.
Materials and Methods
Study design
We looked for pathogen-specific circulating ASCs in patients with acute sinusitis or tonsillitis.
Pathogen-specific ASCs and all immunoglobulin-secreting cells (ISCs) and their isotype
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distributions were analyzed using enzyme-linked immunospot (ELISPOT) assay, and the
expressions of HRs (α4β7–integrin, L-selectin, and CLA) were examined by combining immu-
nomagnetic cell sorting and ELISPOT (Fig 1). While the ASCs represent a population of close
to end-stage B cells producing antibodies specific to each patient’s own pathogen, all ISC
denote the total of various ASC specific to the variety of recently encountered antigens.
The study protocol was approved by the Ethics Committee of the Helsinki University Hos-
pital (411/E5/02:387/2002, approval for continuation 8122010). Healthy volunteers served as
controls. Written informed consent was obtained from all volunteers.
Patients and healthy volunteers
A total of 24 outpatients visiting the emergency room of the Department of Otorhinolaryngol-
ogy at Helsinki University Hospital or the Central Hospital of Central Finland participated in
the study, 13 with acute bacterial maxillary sinusitis and 11 with acute tonsillitis. The diagnosis
of acute sinusitis was based on a combination of typical patient history (e.g. nasal congestion,
purulent nasal discharge, facial pain or pressure, and impaired sense of smell) and purulent
Fig 1. Flow diagram of the study.
doi:10.1371/journal.pone.0154594.g001
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discharge with bacteria (105 cfu / mL) obtained by maxillary irrigation. Likewise, the diagno-
sis of acute tonsillitis relied on typical patient history (e.g. fever, sore throat, anterior cervical
lymphadenopathy) and Streptococcus haemolyticus growth in throat culture (105 cfu / mL).
We only enrolled patients with a positive bacterial culture and symptoms lasting less than two
weeks. Table 1 summarizes the patients’ background data. Nine healthy volunteers, six women
and three men, aged 29 to 46, served as controls.
Bacterial pathogen
Maxillary irrigation (sinusitis group) was carried out and throat swabs taken (tonsillitis group)
by an otologist during the first visit. The pathogen was isolated according to the routines of the
microbiological laboratories of the attending hospitals. Each isolate was then suspended in
0.9% saline solution and killed by adding formaldehyde at a concentration of 2%. The concen-
tration was adjusted to 108 bacteria/ml PBS according to the McFarland standard [21] and the
suspension used in the ELISPOT for pathogen-specific ASC (see below).
Blood samples
Blood samples were drawn 5–7 days after the maxillary irrigation or throat culture. For sinusi-
tis patients this was a routinely scheduled follow-up visit. To allow comparisons between the
Table 1. Patient demographics, clinical picture and number of specific ASCs.
Sample no. Age Gender Pathogen Daya Fever °C CRP mg/L ASCsb/106 PBMC
Sinusitis S1 53 F H. inﬂuenzae 11 39 NAc 58
S2 34 M S. pneumoniae 10 39 45 268
S3 19 M S. pneumoniae 7 38.8 139 651
S4 77 F H. inﬂuenzae 10 NA 44 102
S5 35 M S. pneumoniae 10 37 NA 1256
S6 31 M H. inﬂuenzae 10 39 150 14
S7 55 M S. anginosus 9 <37 NA 10
S8 24 F S. pneumoniae 14 NA 119 104
S9 25 F S. pneumoniae 12 38 121 22
S10 59 M H. inﬂuenzae 7 <37 102 105
S11 56 F S. pneumoniae 7 <37 NA 205
S12 35 F H. inﬂuenzae 10 38 NA 229
S13 23 M H. inﬂuenzae 12 39 92 287
Tonsillitis T1 33 F S. pyogenes 7 NA NA 84
T2 35 F S. pyogenes 7 NA NA 171
T3 29 F S. pyogenes 7 39 NA 40
T4 20 M S. pyogenes 5 NA 57 11
T5 31 M S. pyogenes /S. aureus 7 41 140 8/11
T6 25 F S. pyogenes 7 39 240 51
T7 23 M S. pyogenes 9 39 176 24
T8 28 F beta-hemolytic Streptococcus 7 NA 57 55
T9 25 F beta-hemolytic Streptococcus 10 39 160 108
T10 26 F S. pyogenes 7 NA NA 322
T11 40 F S. pyogenes 7 NA NA 26
a Symptoms in days indicate the number of days the symptoms had lasted before the blood sample was drawn.
b (IgA + IgG + IgM) ASCs
c NA = data not available.
doi:10.1371/journal.pone.0154594.t001
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two groups, the same timing was used for tonsillitis patients. Table 1 presents time points of
sampling with respect to the onset of symptoms.
Isolation of mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized venous blood by
Ficoll-Paque centrifugation as previously described [8].
Separation of cells into HR-negative and -positive cell populations
PBMC were sorted into HR-positive and -negative cell subpopulations by their expressions of
α4β7, L-selectin and CLA using immunomagnetic cell sorting as described earlier [20, 21]. In
short, 3 x 106 PBMC were incubated with one of the receptor-specific anti-human monoclonal
antibodies (mAb): anti-L-selectin (Leu-8), anti-α4β7 (ACT-1) or anti-CLA (HECA-452, a gift
from Dr S. Jalkanen and Dr E.C. Butcher). After washing, the cells were incubated with Dynal
M-450 magnetic beads coated with sheep anti-mouse IgG (Oslo, Norway). After separation,
the receptor-positive and receptor-negative subpopulations were analyzed for antibody pro-
duction using the ELISPOT assay. We have previously reported on the efficiency of the separa-
tion process [20].
Assay of circulating ASCs and ISCs
The ELISPOT analysis of pathogen-specific ASCs and all ISCs (IgA, IgG, and IgM) in the total
PBMC population and the receptor-positive and -negative subpopulations was carried out as
described previously [8, 9, 27, 28]. In brief, to assess pathogen-specific ASC, 96-well microtiter
plates were coated with a suspension of each patient’s own pathogenic strain. In the ISC assay,
human IgA, IgM, (Dako, Glostrup, Denmark) or IgG (Sigma, Immuno Chemicals, St. Louis,
MO, US) -specific antisera (diluted in PBS) were used. After washing and masking the wells,
aliquots of the total PBMC populations or the receptor-positive and negative subpopulations
were added. The antibodies/ immunoglobulins secreted by the cells were then detected with
alkaline phosphatase-conjugated anti-human IgA, IgG (Sigma) or IgM (Southern Biotech, Bir-
mingham, AL) followed by the substrate (5-bromo-4-chloro-3-indolyl phosphate, Sigma) in
melted agarose. Under a microscope, each spot was interpreted as a print of a single ASC or
ISC.
The nine healthy volunteers, six women and three men, were examined for ASCs against a
panel of four Streptococcus pyogenes, two Haemophilus influenzae, one Staphylococcus aureus,
and one Streptococcus pneumoniae strain, each initially isolated from one of the patients in the
present study.
Statistical analysis
The frequencies of pathogen-specific ASCs (IgA+IgG+IgM)/106 PBMC or all ISCs (IgA+IgG
+IgM)/106 PBMC were given as geometric means, and 95% confidence intervals (95% CI)
counted using bootstrapping. The frequencies between the study groups were compared by
independent-samples Kruskal-Wallis test (SPSS 22.01; SPSS Inc.) or independent-samples
Median test in case of high variance across the outcomes [29].
For each patient, the percentages of ASCs expressing a given HR were calculated as follows:
% receptor-positive ASC = 100 x [number of ASC in receptor-positive population] / [total of ASC
in receptor-positive and -negative populations]. And respectively for ISCs of each patient or
control: % receptor-positive ISC = 100 x [number of ISC in receptor-positive population] / [total
of ISC in receptor-positive and -negative populations].
Immune Defense in Upper Airways
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The proportion of cells expressing the various HRs was given as arithmetic means ±SD,
and, when appropriate, compared with independent-samples Mann-Whitney U test or related-
samples Wilcoxon Signed Rank test. To obtain reliable statistics, we included only study sub-
jects with 20 spots identified in the HR analyses. In all tests, p< .05 was considered
significant.
Results
Number of ASCs and ISCs
ASCs specific to each individual’s own pathogen were detected in all patients with acute sinusi-
tis (13/13) and acute tonsillitis (11/11) (Table 1). In acute sinusitis, the geometric mean of the
pathogen-specific ASCs (IgA + IgG + IgM) /106 PBMC was 115 (95%CI 46–282), and in acute
tonsillitis 48 (27–88) (Fig 1). The response proved slightly higher in sinusitis than tonsillitis,
p = .041. None of the six healthy volunteers had ASCs specific to any of the pathogens in the
panel (see above).
The geometric mean of ISCs (IgA + IgG + IgM) /106 PBMC in those with acute sinusitis
was 8689 (95%CI 3952–17020), those with acute tonsillitis 9532 (5695–16554), and in healthy
controls 1135 (887–1420) (Fig 2). The ISC number proved higher in the patient groups than
controls (p = .001 for sinusitis and .003 for tonsillitis); no difference was seen between the two
patient groups (p = .1).
Ig isotype distributions of ASC and ISC
In the sinusitis group, the geometric mean was 72 (95% CI 32–142) /106 PBMC for the patho-
gen-specific IgG-ASCs, 18 (4–77) for IgA-ASCs, and 5 (2–12) for IgM-ASCs (Fig 3A).
IgG-ASCs were detected in all of these patients, IgA-ASC in 10/13, and IgM in 8/13; IgG iso-
type predominated in 9/13 and IgA in 4/13.
Fig 2. Geometric mean of pathogen-specific ASCs and all ISCs. The bars indicate geometric means
(±SEM) of the number of ASCs and ISCs in the peripheral blood of patients with bacterial acute sinusitis,
bacterial acute tonsillitis, and in healthy controls (IgA + IgG + IgM) ASCs or -ISCs/106 PBMC). The patient
samples were examined 7–14 days after the onset of symptoms. The number of volunteers fromwhom the data
were pooled is shown under each bar. Differences between the distributions of the groups were tested with
independent samples Median test (for ASC) or independent samples Kurskal-Wallis (for ISC). NS–p > .05.
doi:10.1371/journal.pone.0154594.g002
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In the tonsillitis group, the geometric means of IgG-, IgA- and, IgM-ASCs were 29 (95%CI
14–60), 5 (2–15), and 6 (2–16) /106 PBMC, respectively (Fig 3B). IgG-ASCs were detected in
all patients, IgA-ASC in 6/11, and IgM in 8/11; IgG-ASCs predominated in 9/11 and IgA- or
IgM-ASC each in 1/11 volunteers (Fig 3B).
Circulating ISCs (Fig 2) were seen in all three isotypes in all patients and controls (data not
shown), indicating that none had agammaglobulinemia. IgG-ISC predominated in all three
groups, IgA-ISC in one patient in both of the patient groups and in two control subjects.
Expression of α4β7, L-selectin, and CLA on pathogen-specific ASCs and
ISCs
The proportion of ASCs expressing the various HRs was similar in the two patient groups: α4β7
was expressed by 24% ± 23 of ASC in sinusitis and 15% ± 12 in tonsillitis (Fig 4). The respective
figures for L-selectin were 82% ± 13 and 80% ± 13, and for CLA 21% ± 16 and 23% ± 12 (Fig
4). As for ISCs, α4β7 integrin was expressed by 35% ± 14, 38% ± 13 and 50% ± 13 of all ISCs in
the sinusitis, tonsillitis and control groups respectively. The respective proportions for L-selec-
tin were 65% ± 14, 73% ± 13, and 59% ± 9, and for CLA 27% ± 17, 31% ± 11, and 23% ± 10.
Comparison of HR expressions between patients’ ASCs and ISCs
The HR data on the two patient groups’ ASCs were pooled to allow comparison between the
same patients’ ASCs and ISCs. The proportion of L-selectin+ cells was higher among ASCs
than ISCs (p = .010), while that of α4β7 or CLA did not differ between ASCs and ISCs (Fig 5).
Discussion
This study is the first to show that acute bacterial URTI is followed by a response of circulating
pathogen-specific plasmablasts, and that human nasopharynx-associated lymphoid structures
disseminate these immune effector cells with a unique homing profile.
Fig 3. Isotype distributions of pathogen-specific ASCs in patients with (A) acute sinusitis and (B) tonsillitis.
The dots represent the number of circulating pathogen-specific IgA, IgG or IgM ASCs (/106 PBMC) of single patients,
the values for different Ig-isotypes are joined with a line. The horizontal lines indicate geometric means (sinusitis n = 11,
tonsillitis n = 7).
doi:10.1371/journal.pone.0154594.g003
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Response of URT-originating plasmablasts–comparison with other
mucosal sites
Circulating pathogen-specific plasmablasts were found in all patients with acute sinusitis or
tonsillitis, concurring with studies showing respective cells in viral URTI [12] and after intrana-
sal immunization [13–15, 22, 23]. Likewise, we recently identified circulating pathogen-specific
plasmablasts in patients with LRTI caused by Streptococcus pneumoniae [28]. Such circulating
Fig 4. Expression of α4β7, L-selectin, and CLA on pathogen-specific ASCs in acute sinusitis and
tonsillitis. The bars indicate arithmetic means (±SD) of percentages of cells expressing the given HR among
all ASC. The number of patients from whom the data were pooled is indicated under each bar. No significant
differences were seen between the study groups in the expressions of the various HR when tested using
independent-samples Mann-Whitney U test.
doi:10.1371/journal.pone.0154594.g004
Fig 5. Comparison of proportions of α4β7-, L-selectin-, and CLA-expressing cells between ASCs and
ISCs of the same patients. Data of patients with acute sinusitis and tonsillitis were pooled. The number of
subjects is shown under each bar. Related-samplesWilcoxon Signed Rank test was used in comparisons
between the same patients’ ASCs and ISCs; p-values are shown above the bars (NS = p > .05).
doi:10.1371/journal.pone.0154594.g005
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mucosa-originating plasmablasts representing cells newly activated at local inductive sites have
also been found in infections at other mucosal sites, e.g. gastroenteritis [9, 21, 30] and lower
[27, 31] and upper [27, 32, 33] urinary tract infection, both in adults [27, 31, 32] and children
[33]. In the URTI the inductive site is the nasopharynx-associated lymphoid tissue, NALT,
which consists of Waldeyer’s ring (refers mainly to adenoids and palatine tonsils) [34] and
occasional lymphoid follicles scattered in the nasal mucosa [34, 35]. The appearance of such
NALT-originating lymphocytes in the circulation may offer a valuable tool for research into
the URT mucosal immune system in humans.
Timing of blood sampling
Plasmablasts are known to appear only transiently in the circulation. The kinetics of this
response has been explored with oral [7, 8, 10] and rectal [19] vaccines, and in gastroenteritis
[11]. The cells appear in the circulation approximately three days after antigen encounter, peak
on day seven, and disappear by day 14–16 [7–11, 36], the latter a consequence of their homing
to the effector sites. A persisting antigenic stimulus may prolong the presence of plasmablasts
in the blood [10, 11]. Accordingly, to catch the peak or come near it, we drew the blood sam-
ples on day 7–14 after the onset of symptoms. This timing appeared feasible, since plasmablasts
were detected in all subjects. As we enrolled only patients with acute disease, the timing appears
comparable in the two groups.
Magnitude of plasmablast response
The magnitude of the URTI plasmablast response was found to be slightly lower than that
found in our recent LRTI study [37]. This may reflect the less severe nature of sinusitis or ton-
sillitis compared to pneumonia, analogous to lower vs higher urinary tract infection reported
in our previous study [27]. In sinusitis the plasmablast response was somewhat greater than in
tonsillitis, which may imply a wider dissemination to local inductive sites in sinusitis.
Immunoglobulin distribution of plasmablast response
IgG proved the most prevalent Ig isotype in both sinusitis and tonsillitis. This accords with previ-
ous vaccination studies of the human URT: tonsillar cholera immunizations [13] and intranasal
influenza vaccinations [15] have been shown to induce an IgG-dominated plasmablast response
in the circulation [13, 15] and in tonsils and adenoids [13]. IgG isotype also dominates in the
plasmablast response in pneumonia [28]. Indeed, despite the well-known role of IgA as the
mucosal antibody at all other mucosal sites [7–9, 21, 27, 28, 38] IgG appears to serve a more
important function in the respiratory tract. Interestingly, besides the predominance of IgG plas-
mablasts in both, IgA cell response was seen more commonly in patients with sinusitis (10/13)
than tonsillitis (6/11). The presence of a mucosal secretory system with abundant polymeric IgA,
J-chain and specific epithelial elements of pIgR/SC has been reported in adenoids, but not in pal-
atine tonsils [34]. Thus, the greater frequency of IgA-ASC responses in patients with sinusitis
than tonsillitis may reflect a more pronounced B cell priming in adenoids in this disease.
Homing profiles of plasmablasts in tonsillitis and sinusitis
The overall homing profiles of the pathogen-specific plasmablasts were similar in the two study
groups: most cells expressed L-selectin, and less than one quarter α4β7 or CLA. This similarity
suggests involvement of the same activation sites. The data reveal a distinct homing profile for
plasmablasts elicited at the URT: the profile differs not only from that described for diarrhea
(α4β7
high, L-selectinlow, CLA neglible) [21, 32] or upper urinary tract infection (α4β7
moderate/high,
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L-selectinmoderate/high, CLAlow) [32], but also for lower respiratory tract infection (α4β7
moderate,
L-selectinhigh, CLAlow) [37]. The profile appeared to resemble most closely the systemic type of
immune response (α4β7
low, L-selectinhigh CLA low) elicited by parenteral vaccination [32, 20, 23].
As the site of antigen encounter determines the homing commitments of the newly acti-
vated lymphocytes [6, 19–26], it is of interest to consider each of the HR separately. The high
proportion of L-selectin+ plasmablasts (sinusitis 80%, tonsillitis 82%) corresponds to that
described for pneumonia (79%) [37] or elicited by nasal vaccination (80–90%) [23]. Consis-
tently, the entire respiratory tract is characterized by an abundance of peripheral-node addres-
sins (PNAd) [39, 40]. As for T cells, only a low/negligible frequency of L-selectin-expressing
cells has been found in human lungs [41, 42], suggesting that strong L-selectin involvement in
the respiratory tract may be unique for effector B cells. Moreover, comparison with infections
at other mucosal sites [32, 21, 37] suggests that the great frequency of L-selectin+ cells may
only be characteristic of URT- and LRT-originating plasmablasts. Likewise, in the present
study, L-selectin was expressed more frequently by the pathogen-specific plasmablasts than the
same patients’ total population of ISC, the latter comprising a collection of end-stage B cells
recently activated at various sites of the body.
As regards α4β7, the data do not suggest a central function for it in targeting URT-origi-
nating plasmablasts. Even though the main ligand for α4β7, the intestinal MadCAM-1, is
reported to be expressed also on venules of the URT, only 24% (in sinusitis) and 15% (in ton-
sillitis) of the URT-originating plasmablasts expressed α4β7. This contrasts with our previous
investigation of the LRT, where a substantial expression of α4β7 was seen in pneumonia
patients (44%) [37]. Our data also contradict previous HR studies of URT-originating B cells
induced by intranasal immunization; Quiding-Järbrink et al have reported considerable pro-
portions of both α4β7- and L-selectin-expressing cells among plasmablasts after intranasal
cholera toxin immunization [23]. The reason for this discrepancy remains unclear. It could
reflect the nature of the antigen (cholera toxin is an immunoadjuvant), for example, or alter-
natively, it could attest to differing inductive sites in intranasal vaccination vs natural infec-
tion. The various parts of Waldeyer’s Ring may equip immune effector cells differently, as
suggested by the differences in the IgA system [34] discussed above. The response elicited by
intranasal vaccination might thus be predominantly stimulated in the adenoids, and in both
adenoids and palatine tonsils in natural infection. However, an acute infection can occasion-
ally elicit a response with a great proportion of α4β7 cells, as evidenced by our two sinusitis
cases (65% and 77%); this may suggest a more central function for adenoids as inductive sites
in these patients.
The low frequency of CLA (21% in sinusitis and 23% in tonsillitis) apparently ensures the
cells’ efficient targeting to the upper respiratory tract, avoiding a simultaneous “loss” of cells to
undesired sites, such as the skin.
Our assay as such does not provide data on possible co-expression of the various HR. How-
ever, were the proportions of receptor-positive cells with various HR totaled (α4β7-, L-selectin-
and CLA-positive cells), the result would exceed 100% in 9/13 and 6/11 patients with tonsillitis
or sinusitis, respectively.
Limitations
Two limitations deserve to be mentioned: the small number of subjects and coverage of mark-
ers. We only investigated three homing receptors, other potential HRs as well as chemokine
receptors were excluded. However, we have applied the same selection in our previous research
into the LRT, gastrointestinal and urinary tract infections, which enables comparison between
the various mucosal sites with respect to each of these markers.
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Conclusions
We demonstrated that acute bacterial URTI induces pathogen-specific plasmablasts in the cir-
culation, with IgG plasmablasts as the predominating isotype. A characteristic homing profile
with a high proportion of L-selectin and scant α4β7 and CLA, was revealed for the upper air-
ways, differing from that reported previously for infections at other mucosal sites.
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